Back to results

UnknownPhase 2

Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer

NCT03048942

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Imperial Healthcare NHS Trust

London, Avon, United Kingdom

+12 additional locations

Contact

Amit K Bahl

0117 342 2418 amit.bahl@uhbristol.nhs.uk

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2014-11
Enrollment: 160 participants
Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust
Purpose: treatment

Locations (13)

Imperial Healthcare NHS TrustLondon, Avon, United Kingdom
Royal United HospitalBath, United Kingdom
Blackpool Victoria HospitalBlackpool, United Kingdom
Bristol Haematology and Oncology Centre, Horfield RoadBristol, United Kingdom
Velindre Cancer CentreCardiff, United Kingdom
Royal Devon and Exeter HospitalExeter, United Kingdom
Guy's HospitalLondon, United Kingdom
Freeman HospitalNewcastle, United Kingdom
City Hospital, NottinghamNottingham, United Kingdom
Derriford HospitalPlymouth, United Kingdom
Musgrove Park HospitalTaunton, United Kingdom
Royal Cornwall and TreliskeTruro, United Kingdom
Worcestershire Acute Hospitals NHS TrustWorcester, United Kingdom

Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer — TrialFind